Sequence analysis of two nuclear encoded subunits (10 and 51 kDa) of mitochondrial complex I in Parkinson disease

Haass C, Kahle PJ (2001) Neuroscience. Parkin and its substrates. Science 293:224–225PubMedCrossRefGoogle Scholar

Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990) Mitochondrial complex I deficiency in Parkinson’s disease. J Neurochem 54:823–827PubMedCrossRefGoogle Scholar

Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson’s disease. Lancet I:1269CrossRefGoogle Scholar

Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson’s disease. Biochem Biophys Res Comm 163:1450–1455PubMedCrossRefGoogle Scholar

Janetzky B, Hauck S, Youdim MB, Riederer P, Jellinger K, Pantucek F, Zochling R, Boissl KW, Reichmann H (1994) Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson’s disease. Neurosci Lett 169:126–128PubMedCrossRefGoogle Scholar

Davey GP, Peuchen S, Clark JB (1998) Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. J Biol Chem 273:12753–12757PubMedCrossRefGoogle Scholar

Goldberg MS, Lansbury PT Jr (2000) Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson’s disease? Nat Cell Biol 2:E115–E119PubMedCrossRefGoogle Scholar

Kapsa RM, Jean Francois MJ, Lertrit P, Weng S, Siregar N, Ojaimi J, Donnan G, Masters C, Byrne E (1996) Mitochondrial DNA polymorphism in substantia nigra. J Neurol Sci 144:204–211PubMedCrossRefGoogle Scholar

Kösel S, Grasbon-Frodl EM, Mautsch U, Egensperger R, Eitzen U von, Frishman D, Hofmann S, Gerbitz KD, Mehraein P, Graeber MB (1998) Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease. Neurogenetics 1:197–204PubMedCrossRefGoogle Scholar

Simon DK, Mayeux R, Marder K, Kowall NW, Beal MF, Johns DR (2001) Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson’s disease. Neurology 54: 703–709CrossRefGoogle Scholar

Hattori N, Yoshino H, Tanaka M, Suzuki H, Mizuno Y (1998) Genotype in the 24-kDa subunit gene (NDUFV2) of mitochondrial complex I and susceptibility to Parkinson disease. Genomics 49:52–58PubMedCrossRefGoogle Scholar

Ohnishi T, Ragan CI, Hatefi Y (1985) EPR studies of iron-sulfur clusters in isolated subunits and subfractions of NADHubiquinone oxidoreductase. J Biol Chem 260:2782–2788PubMedGoogle Scholar

Kösel S, Grasbon-Frodl EM, Hagenah JM, Graeber MB, Vieregge P (2001) Parkinson disease: analysis of mitochondrial DNA in monozygotic twins. Neurogenetics 2:227–230CrossRefGoogle Scholar

Schuelke M, Smeitink J, Mariman E, Loeffen J, Plecko B, Trijbels F, Stockler-Ipsiroglu S, Heuvel L van den (1999) Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet 21:260–261PubMedCrossRefGoogle Scholar

Smeitink J, Heuvel L van den (1999) Human mitochondrial complex I in health and disease. Am J Hum Genet 64:1505–1510PubMedCentralPubMedCrossRefGoogle Scholar